Skip to main content
Clinical Trials/TCTR20240417004
TCTR20240417004
Recruiting
Phase 3

Efficacy of Intra-articular Ketorolac with Corticosteroid versus Corticosteroid Injection Alone In Adhe-sive Capsulitis of the Shoulder: A Triple blind randomized controlled trial

erdsin Hospital, Thailand0 sites36 target enrollmentApril 17, 2024

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
erdsin Hospital, Thailand
Enrollment
36
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 17, 2024
End Date
October 31, 2025
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
erdsin Hospital, Thailand

Eligibility Criteria

Inclusion Criteria

  • Adhesive capsulitis stage 1 (Freezing) and stage 2 (Frozen)
  • Shoulder pain and indication for intra\-articular injection
  • Age 18\-65 years

Exclusion Criteria

  • Concomitant massive rotator cuff tendinopathy
  • Concomitant abnormal X\-ray : GH OA, neoplasm
  • Pain related to AC joint pathology
  • History of pre\-existing shoulder pathological : infection, trauma
  • Neurological disorder : CSR or stroke
  • Drug allergy or contraindication : ketorolac, ASA, NSAIDs, TA, lidocaine
  • Underling disease : Rheumatoid arthritis, on warfarin

Outcomes

Primary Outcomes

Not specified

Similar Trials